Kilpelainen A - Search Results

1

Viral and Cellular Factors Leading to the Loss of CD4 Homeostasis in HIV-1 Viremic Nonprogressors.

Colomer-Lluch M, Kilpelainen A, Pernas M, Peña R, Ouchi D, Jimenez-Moyano E, Dalmau J, Casado C, López-Galíndez C, Clotet B, Martinez-Picado J, Prado JG. Colomer-Lluch M, et al. Among authors: kilpelainen a. J Virol. 2022 Jan 12;96(1):e0149921. doi: 10.1128/JVI.01499-21. Epub 2021 Oct 20. J Virol. 2022. PMID: 34668779 Free PMC article.

2

Skewed Cellular Distribution and Low Activation of Functional T-Cell Responses in SARS-CoV-2 Non-Seroconvertors.

Kilpeläinen A, Jimenez-Moyano E, Blanch-Lombarte O, Ouchi D, Peña R, Quirant-Sanchez B, Perez-Caballero R, Chamorro A, Blanco I, Martínez-Caceres E, Paredes R, Mateu L, Carrillo J, Blanco J, Brander C, Massanella M, Clotet B, Prado JG. Kilpeläinen A, et al. Front Immunol. 2022 May 10;13:815041. doi: 10.3389/fimmu.2022.815041. eCollection 2022. Front Immunol. 2022. PMID: 35619701 Free PMC article.

3

SARS-CoV-2 Consensus-Sequence and Matching Overlapping Peptides Design for COVID19 Immune Studies and Vaccine Development.

Olvera A, Noguera-Julian M, Kilpelainen A, Romero-Martín L, Prado JG, Brander C. Olvera A, et al. Among authors: kilpelainen a. Vaccines (Basel). 2020 Aug 6;8(3):444. doi: 10.3390/vaccines8030444. Vaccines (Basel). 2020. PMID: 32781672 Free PMC article.

4

Recombinant BCG Expressing HTI Prime and Recombinant ChAdOx1 Boost Is Safe and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice.

Kilpeläinen A, Saubi N, Guitart N, Olvera A, Hanke T, Brander C, Joseph J. Kilpeläinen A, et al. Vaccines (Basel). 2019 Aug 2;7(3):78. doi: 10.3390/vaccines7030078. Vaccines (Basel). 2019. PMID: 31382453 Free PMC article.

5

Priming with Recombinant BCG Expressing HTI Enhances the Magnitude and Breadth of the T-Cell Immune Responses Elicited by MVA.HTI in BALB/c Mice.

Saubi N, Kilpeläinen A, Eto Y, Chen CW, Olvera À, Hanke T, Brander C, Joseph-Munné J. Saubi N, et al. Among authors: kilpelainen a. Vaccines (Basel). 2020 Nov 13;8(4):678. doi: 10.3390/vaccines8040678. Vaccines (Basel). 2020. PMID: 33202884 Free PMC article.

6

Short communication: HIV-1 Nef protein carries multiple epitopes suitable for induction of cellular immunity for an HIV vaccine in Africa.

Kilpeläinen A, Axelsson Robertson R, Leitner T, Sandström E, Maeurer M, Wahren B. Kilpeläinen A, et al. AIDS Res Hum Retroviruses. 2014 Nov;30(11):1065-71. doi: 10.1089/AID.2013.0299. Epub 2014 Jul 16. AIDS Res Hum Retroviruses. 2014. PMID: 24866397 Free PMC article.

7

Priming With Recombinant BCG Expressing Novel HIV-1 Conserved Mosaic Immunogens and Boosting With Recombinant ChAdOx1 Is Safe, Stable, and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice.

Kilpeläinen A, Saubi N, Guitart N, Moyo N, Wee EG, Ravi K, Hanke T, Joseph J. Kilpeläinen A, et al. Front Immunol. 2019 May 14;10:923. doi: 10.3389/fimmu.2019.00923. eCollection 2019. Front Immunol. 2019. PMID: 31156614 Free PMC article.

8

Advances and challenges in recombinant Mycobacterium bovis BCG-based HIV vaccine development: lessons learned.

Kilpeläinen A, Maya-Hoyos M, Saubí N, Soto CY, Joseph Munne J. Kilpeläinen A, et al. Expert Rev Vaccines. 2018 Nov;17(11):1005-1020. doi: 10.1080/14760584.2018.1534588. Epub 2018 Nov 9. Expert Rev Vaccines. 2018. PMID: 30300040 Review.

9

MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against Mycobacterium tuberculosis in Mice.

Broset E, Saubi N, Guitart N, Aguilo N, Uranga S, Kilpeläinen A, Eto Y, Hanke T, Gonzalo-Asensio J, Martín C, Joseph-Munné J. Broset E, et al. Among authors: kilpelainen a. Mol Ther Methods Clin Dev. 2019 Feb 7;13:253-264. doi: 10.1016/j.omtm.2019.01.014. eCollection 2019 Jun 14. Mol Ther Methods Clin Dev. 2019. PMID: 30859110 Free PMC article.

10

Oxidative stress induced by HIV-1 reverse transcriptase modulates the enzyme's performance in gene immunization.

Isaguliants M, Smirnova O, Ivanov AV, Kilpelainen A, Kuzmenko Y, Petkov S, Latanova A, Krotova O, Engström G, Karpov V, Kochetkov S, Wahren B, Starodubova E. Isaguliants M, et al. Among authors: kilpelainen a. Hum Vaccin Immunother. 2013 Oct;9(10):2111-9. doi: 10.4161/hv.25813. Epub 2013 Jul 23. Hum Vaccin Immunother. 2013. PMID: 23881028 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters